These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1901494)

  • 21. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 22. New strategy of thrombolysis. Conjunctive effect of plasminogen activators with different pharmacokinetic profile.
    Maksimenko AV
    Ann N Y Acad Sci; 1998 Dec; 864():96-105. PubMed ID: 9928084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.
    Maksimenko AV; Tischenko EG; Golubykh VL
    Ann N Y Acad Sci; 1998 Dec; 864():409-17. PubMed ID: 9928118
    [No Abstract]   [Full Text] [Related]  

  • 25. Clot-specific thrombolytic agents: is there an advantage?
    Pitt B
    J Am Coll Cardiol; 1988 Sep; 12(3):588. PubMed ID: 3403816
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular mechanisms of thrombolysis: implications for therapy.
    Collen D; Lijnen HR
    Biochem Pharmacol; 1990 Jul; 40(2):177-86. PubMed ID: 2115776
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategies for the improvement of thrombolytic agents.
    Lijnen HR; Collen D
    Thromb Haemost; 1991 Jul; 66(1):88-110. PubMed ID: 1926054
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality].
    Maksimenko AV
    Biomed Khim; 2014; 60(6):677-82. PubMed ID: 25552508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism of thrombolytic agents in vivo.
    Collen D; Stassen JM; Stump DC; Verstraete M
    Circulation; 1986 Oct; 74(4):838-42. PubMed ID: 3093116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fibrinolytic agents in the prevention of postoperative adhesion formation.
    Hellebrekers BW; Trimbos-Kemper TC; Trimbos JB; Emeis JJ; Kooistra T
    Fertil Steril; 2000 Aug; 74(2):203-12. PubMed ID: 10927033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of the thrombolytic efficacy of single-chain urokinase (Pro-urokinase) by heparin.
    Gulba DC; Fischer K; Reil GH; Daniel WG; Lichtlen PR
    Thromb Haemost; 1988 Oct; 60(2):350-1. PubMed ID: 3146150
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasminogen activators and thrombolytic therapy].
    Taran LD
    Biomed Khim; 2005; 51(3):248-62. PubMed ID: 16104388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ideal fibrinolytic: can drug design improve clinical results?
    Van de Werf FJ
    Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843
    [No Abstract]   [Full Text] [Related]  

  • 36. [Structure of the natural plasminogen activator (t-PA) and of reteplase. Controversies on thrombolytic therapy. 45th yearly session of the American College of Cardiology. Orlando, Fla. March 1996].
    Dtsch Med Wochenschr; 1996; 121(36 Suppl Fur Praxis):1-8. PubMed ID: 9401482
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
    von Hodenberg E; Kreuzer J; Hautmann M; Nordt T; Kübler W; Bode C
    Am J Cardiol; 1991 Jun; 67(16):1349-53. PubMed ID: 1828324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2005 Nov; 25(4):345-55. PubMed ID: 16395484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.